Vaxil Bio Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was CAD 0.125 million compared to CAD 0.126 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | 0.00% | -40.00% |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 1.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VXL Stock
- News Vaxil Bio Ltd.
- Vaxil Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023